Welcome to our dedicated page for Acacia Resh news (Ticker: ACTG), a resource for investors and traders seeking the latest updates and insights on Acacia Resh stock.
Acacia Research Corp (ACTG) delivers strategic value through patent licensing expertise and technology-driven acquisitions. This news hub provides investors and professionals with essential updates on intellectual property developments, operational milestones, and financial performance.
Access timely press releases covering patent portfolio monetization, industrial sector acquisitions, and partnership announcements. Our curated news collection enables users to track ACTG's progress in transforming underutilized assets into revenue-generating opportunities across multiple industries.
Key content categories include earnings reports, licensing agreements, strategic investments, and management updates. Each update is selected for its relevance to understanding the company's dual focus on IP commercialization and diversified business operations.
Bookmark this page for direct access to verified information about ACTG's activities in technology commercialization and value-driven acquisitions. Regularly updated to reflect the company's latest moves in patent licensing markets and operational expansions.
Acacia Research Corporation (ACTG) reported $15.9 million in revenue for Q3 2022, a significant increase from $1.6 million in Q3 2021. The company achieved $36.1 million in realized gains from equity securities, totaling $265 million in gains from its Life Science Portfolio. Acacia repaid $55 million in Senior Secured Notes and completed a $40 million stock repurchase program. Despite a GAAP net income of $28.1 million, the company recorded an operating loss of $11.4 million. Book value decreased to $282.5 million, with a pro forma value potentially reaching $520.1 million post-recapitalization with Starboard.
Acacia Research Corporation (NASDAQ: ACTG) will announce its third quarter 2022 financial results before the market opens on November 10, 2022. The company is hosting a conference call on the same day at 11:00 a.m. ET to discuss the results, which can be accessed by calling 888-506-0062 (U.S.) or 973-528-0011 (international), using conference ID 958547. The call will also be available via webcast on Acacia's investor relations website for 30 days post-event.
Acacia Research Corporation (NASDAQ: ACTG) announced a transformative agreement with Starboard Value LP, which will invest over $245 million and convert all ownership interests to common shares. CEO Clifford Press is retiring, with MJ McNulty appointed as interim CEO. The deal simplifies Acacia's capital structure, eliminating $133.2 million of derivative liabilities and $95 million in debt. A rights offering at $5.25 per share is planned, with Starboard committed to buy at least 15 million shares. Acacia's pro forma book value is set to rise by at least $265.7 million.
Acacia Research Corporation (ACTG) has extended the Cash Exercise Date for its Series B Warrants by four weeks, moving it from September 30, 2022 to October 28, 2022. This extension is part of the ongoing discussions between Acacia and Starboard Value LP aimed at simplifying capital structure and enhancing resources for growth. Acacia's CEO, Clifford Press, emphasized the progress made in establishing a suitable capital structure and the urgency in finalizing these arrangements.
Acacia Research Corporation (ACTG) reported a Q2 2022 revenue of $16.7 million, down from $17.4 million in Q2 2021. The company recorded $11.5 million in realized gains, including $5.2 million from its Life Science Portfolio. Acacia repurchased 6.1 million shares at an average price of $4.64 as part of a $40 million buyback program. Additionally, the company repaid $50 million in debt. However, there was a substantial GAAP net loss of $61.5 million compared to a net income of $19.7 million last year.
Acacia Research Corporation (NASDAQ: ACTG) will release its second quarter 2022 financial results on August 11, 2022, before market opening. A conference call will follow at 11:00 a.m. ET to discuss the results. To participate, dial 888-506-0062 or 973-528-0011 (international) with conference ID 536777. The call will also be available via webcast on the company’s website. Acacia Research focuses on acquiring undervalued businesses to create value through strategic acquisitions, leveraging expertise in corporate governance, operational restructuring, and access to capital.
Acacia Research reported Q1 2022 financial results, achieving $13.5 million in total revenue, a significant increase from $5.8 million in Q1 2021. This included $10.9 million from Printronix, acquired in October 2021. The company recorded $66.9 million in realized gains, primarily from its Life Science Portfolio, and completed a $15 million share repurchase. However, Acacia faced a $73.3 million net loss due to unrealized losses totaling $(172.2 million). The current book value decreased to $7.42 per share.
Acacia Research Corporation (NASDAQ: ACTG) will release its first quarter 2022 financial results before market open on May 12, 2022. A conference call is scheduled for the same day at 11:00 a.m. ET to discuss the results. Interested parties can access the live call by dialing 888-506-0062 for the U.S. or 973-528-0011 internationally, using access code 199065. The call will also be webcasted on the company’s website, with a replay available for 30 days.
Acacia Research Corporation (ACTG) reported strong financial results for the full year 2021, generating $149.2 million in net income, equating to $1.91 per diluted share. This performance was fueled by $76.0 million in revenue from its Intellectual Property segment and $116.1 million in realized gains primarily from its Life Sciences Portfolio. The company completed the acquisition of Printronix for $33 million, contributing $12.0 million to revenues. In 2022, it anticipates revenues between $13.0 million and $14.0 million for Q1, with a new $40 million stock repurchase program approved.
Acacia Research Corporation (NASDAQ: ACTG) will release its fourth quarter and year-end 2021 financial results on March 31, 2022, before the market opens. A conference call to discuss these results is scheduled for 11:00 a.m. ET. Interested parties can access the call by dialing 888-506-0062 in the U.S. or 973-528-0011 internationally. The call will also be webcast on Acacia's investor relations website. Acacia focuses on acquiring undervalued businesses, leveraging flexible capital and operational expertise across various sectors.